70net永乐高

公司介绍

Company Profile

上海汉维生物医药科技有限公司于2008年在被誉为中国硅谷的上海张江高科技园区成立
，是一家集宠物医药健康产品研发、生产与国内外营销于一体的国际化高新技术企业。

深耕中国宠物医药健康领域
，70net永乐高始终秉持“客户第一,伙伴成长”的企业价值观

，专注于抗感染
、皮肤、镇痛
、泌尿、眼科、心血管和体内外驱虫等宠物药领域，持续为客户提供宠物专用新型药品、保健护理产品和专业化服务。截止到2025年1月，70net永乐高已取得国家新兽药证书12个，46个宠物药品批文，研发管线产品50+，成为上万家专业宠物医院的忠实选择
。在弗罗斯特·沙利文发布的《2025中国宠物药物白皮书》中数据显示，70net永乐高为中国国产宠物药线下门店覆盖率第一
。

立足中国发展
，兼具国际视野

。70net永乐高建立了全球研发中心，国际cGMP标准工厂和国际营销中心，具备符合VICH指南的药物剂型设计、配方筛选、方法验证、中试放大和商业化生产等专业服务能力，提供CRO/CMO/Leicense国际业务。产品已实现多国GMP认证，海外5国上市销售。

70net永乐高致力于以专业守护全球宠物健康
，共建人宠友爱的美好世界
。

Shanghai Hanwei Biomedical Technology Co., Ltd. was established in 2008 in Zhangjiang Hi-Tech Park, Shanghai, which is known as China's Silicon Valley.

It is an international high-tech enterprise integrating the research and development, production and domestic and international marketing of pet medical and

health products.

Deeply rooted in the field of pet medicine and health in China, Hanwei Chongshi has always adhered to the corporate values of "Customer first, Partner growth", 

focusing on the areas of pet medicine such as anti-infection, skin care, pain relief, urology, ophthalmology, cardiovascular and internal and external deworming, 

and continuously providing customers with new pet-specific drugs, health care products and professional services. As of January 2025, Hanwei Chongshi has 

obtained 12 new national veterinary drug certificates, 46 pet drug approval documents, and has developed over 50 pipeline products, becoming the loyal choice 

of tens of thousands of professional pet hospitals. According to the "2025 China Pet Medicine White Paper" released by Frost & Sullivan, Hanwei Chongshi has 

the highest offline store coverage rate among domestic pet medicine brands in China.

Based on China's development while also having an international perspective. Hanweicongshi has established a global R&D center, an international cGMP 

standard factory and an international marketing center. It possesses professional service capabilities such as drug dosage form design, formula screening, 

method validation, pilot-scale amplification and commercial production in compliance with VICH guidelines, and provides CRO/CMO/Leicense international 

business. The product has achieved GMP certification in multiple countries and is available for sale in five overseas countries.

Hanwei Pet Care is committed to safeguarding the health of pets worldwide with professionalism and jointly building a beautiful world where humans and pets love 

each other.

附件
：

[1]专利列表

[2]国家新兽药证书